Reference health
Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus
1 of 137 checkable references need attention · checked 2026-07-23
At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.
7 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
References needing attention
does not resolve to a known work10.1042/CS19990056
The 136 checked references that resolve
resolves10.1056/NEJM199807233390404
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
resolves10.1016/S0140-6736(98)07019-6
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
resolves10.3109/07853899608999088
International Variations in Cardiovascular Mortality Associated with Diabetes Mellitus: The WHO Multinational Study of Vascular Disease in Diabetes
resolves10.2337/diacare.22.5.812
Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients.
resolves10.1016/S0009-9120(98)00101-5
Increased plasma apolipoprotein B-containing lipoproteins associated with increased urinary albumin within the microalbuminuria range in type 2 diabetes
resolves10.1161/01.ATV.9.3.335
Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
resolves10.1172/JCI116541
Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles.
resolves10.1161/01.CIR.88.2.381
LDL subclass phenotypes and the insulin resistance syndrome in women.
resolves10.1161/ATVB.17v07.1465
Nonobese Patients With Familial Combined Hyperlipidemia Are Insulin Resistant Compared With Their Nonaffected Relatives
resolves10.1161/01.ATV.9.6.928
Parental history of diabetes is associated with increased cardiovascular risk factors.
resolves10.1001/jama.1990.03440210043030
Cardiovascular Risk Factors in Confirmed Prediabetic Individuals
resolves10.2337/diacare.15.10.1285
Dyslipidemias Among Normoglycemic Members of Familial NIDDM Pedigrees
resolves10.1016/S0021-9150(98)00065-3
Lipoprotein composition and serum apolipoproteins in normoglycaemic first-degree relatives of non-insulin dependent diabetic patients
resolves10.1073/pnas.77.1.604
Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].
resolves10.1016/0021-9150(94)90129-5
Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk
resolves10.1073/pnas.80.21.6662
Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia.
resolves10.1016/S0022-2275(20)38425-X
Plasma very low density lipoproteins contain a single molecule of apolipoprotein B
resolves10.1016/S0009-8981(99)00262-4
Triglyceride and Lp(a) concentrations in hyperapobetalipoproteinemia
resolves10.1016/0021-9150(91)90050-D
Effect of moderate hypertriglyceridemia on the relation of plasma total and LDL apo B levels
resolves10.1093/clinchem/37.10.1676
International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B
resolves10.1093/clinchem/38.5.658
International Federation of Clinical Chemistry Standardization Project for Measurements of Apolipoproteins A-I and B. II. Evaluation and Selection of Candidate Reference Materials
resolves10.1093/clinchem/40.4.586
International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material
resolves10.1093/clinchem/42.4.515
Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study
resolves10.1093/clinchem/44.8.1641
Apolipoprotein B and A-I values in 147 576 Swedish males and females, standardized according to the World Health Organization–International Federation of Clinical Chemistry First International Reference Materials
resolves10.1016/S0022-2275(20)38178-5
Identification of multiple subclasses of plasma low density lipoproteins in normal humans.
resolves10.1172/JCI112360
Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.
resolves10.1016/S0022-2275(20)38079-2
Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma
resolves10.1016/0021-9150(80)90078-7
Transfer of cholesterol esters between human high density lipoproteins and triglyceride-rich lipoproteins controlled by a plasma protein factor
resolves10.1016/0005-2760(91)90096-Z
Effects of various non-esterified fatty acids on the transfer of cholesteryl esters from HDL to LDL induced by the cholesteryl ester transfer protein
resolves10.2337/diacare.22.10.1688
LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study.
resolves10.1097/00041433-199608000-00007
Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease
resolves10.1016/S0002-9149(99)80761-9
Distribution of lipids in 8,500 men with coronary artery disease
resolves10.1016/S0002-9149(99)00209-X
Epidemiology of hypertriglyceridemia and cardiovascular disease
resolves10.1097/00041433-199708000-00005
High density lipoprotein and coronary heart disease: insights from mutations leading to low high density lipoprotein
resolves10.1172/JCI114722
Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.
resolves10.7326/0003-4819-97-6-833
Association of Hyperapobetalipoproteinemia with Endogenous Hypertriglyceridemia and Atherosclerosis
resolves10.1016/0009-8981(78)90038-4
Serum and lipoprotein apolipoprotein B levels in normal subjects and patients with hyperlipoproteinaemia
resolves10.1016/0026-0495(76)90089-5
Myocardial infarction in the familial forms of hypertriglyceridemia
resolves10.1136/hrt.56.3.206
Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction.
resolves10.1136/hrt.60.5.397
High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease.
resolves10.1016/0021-9150(85)90093-0
Clinical significance of measurements of serum apolipoprotein A-I, A-II and B in hypertriglyceridemic male patients with and without coronary artery disease
resolves10.1016/0002-9149(93)91002-Y
Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged ≤50 years) and women (≤60 years) with coronary artery disease
resolves10.1016/S0002-9149(99)80760-7
Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Que´bec cardiovascular study)
resolves10.1161/01.ATV.9.2.176
Comparison of arterial intimal clearances of LDL from diabetic and nondiabetic cholesterol-fed rabbits. Differences in intimal clearance explained by size differences.
resolves10.1016/0021-9150(95)05770-6
Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system
resolves10.1016/S0021-9150(98)00037-9
The atherogenic lipoprotein phenotype and vascular endothelial dysfunction
resolves10.1161/01.ATV.19.3.605
Low-Density Lipoprotein Particle Size Is Inversely Related to Plasminogen Activator Inhibitor-1 Levels
resolves10.1055/s-0038-1665440
Small, Dense LDL Particle Concentration Correlates with Plasminogen Activator Inhibitor Type-1 (PAI-1) Activity
resolves10.1006/bbrc.1993.1550
Low Density Lipoprotein Subfractions Increase Thromboxane Formation in Endothelial Cells
resolves10.1161/01.ATV.11.2.298
Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.
resolves10.1016/S0022-2275(20)40756-4
Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia.
resolves10.1016/S0022-2275(20)42610-0
Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages.
resolves10.1016/0021-9150(96)05842-X
Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans
resolves10.1161/01.RES.73.1.118
Low density lipoprotein subfractions and [Ca2+]i in vascular smooth muscle cells.
resolves10.1016/S0021-9258(18)89180-3
Modulation of apolipoprotein B antigenic determinants in human low density lipoprotein subclasses.
resolves10.1016/S0021-9258(17)42379-9
Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size.
resolves10.1016/S0022-2275(20)34343-1
Studies of low density lipoprotein molecular weight in human beings with coronary artery disease.
resolves10.1001/jama.1988.03410130125037
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
resolves10.1016/S0022-2275(20)35731-X
Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women
resolves10.1001/jama.1996.03540110029028
Association of Small Low-Density Lipoprotein Particles With the Incidence of Coronary Artery Disease in Men and Women
resolves10.1001/jama.1996.03540110036029
A Prospective Study of Triglyceride Level, Low-Density Lipoprotein Particle Diameter, and Risk of Myocardial Infarction
resolves10.1161/01.ATV.19.11.2742
LDL Size and Risk of Coronary Heart Disease in Elderly Men and Women
resolves10.1161/01.CIR.95.1.69
Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in Men
resolves10.1016/S0140-6736(87)92734-6
INTERMEDIATE-DENSITY LIPOPROTEINS AND PROGRESSION OF CORONARY ARTERY DISEASE IN HYPERCHOLESTEROLAEMIC MEN
resolves10.1016/0026-0495(93)90199-X
Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS)
resolves10.1161/01.CIR.94.9.2146
Predominance of Dense Low-Density Lipoprotein Particles Predicts Angiographic Benefit of Therapy in the Stanford Coronary Risk Intervention Project
resolves10.1161/01.ATV.16.5.697
Lipoprotein Subclasses in the Monitored Atherosclerosis Regression Study (MARS)
resolves10.1161/01.CIR.99.15.1959
Evidence for a New Pathophysiological Mechanism for Coronary Artery Disease Regression
resolves10.1161/01.CIR.94.3.273
Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Que´bec Cardiovascular Study
resolves10.2337/diab.41.2.S12
Quantitative and Qualitative Lipoprotein Abnormalities in Diabetes Mellitus
resolves10.2337/diacare.6.3.224
Serum Lipids and Lipoproteins in Insulin-dependent Diabetic Subjects During High-Carbohydrate, High-Fiber Diet
resolves10.1161/01.ATV.12.12.1496
LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes.
resolves10.1007/BF00405083
The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, Type 2 (non-insulin-dependent) diabetic patients
resolves10.1093/ajcn/71.2.412
Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms
resolves10.1002/(SICI)1096-9136(199711)14:11<974::AID-DIA495>3.0.CO;2-I
Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetes
resolves10.1016/0021-9150(93)90084-8
Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient?
resolves10.2337/diab.31.4.283
Nonenzymatic Glucosylation of Low-Density Lipoprotein Alters Its Biologic Activity
resolves10.2337/diab.34.9.938
Nonenzymatic Glycosylation Products on Collagen Covalently Trap Low-Density Lipoprotein
resolves10.1161/01.ATV.19.3.743
Role of Cholesterol Ester Mass in Regulation of Secretion of ApoB100 Lipoprotein Particles by Hamster Hepatocytes and Effects of Statins on That Relationship
resolves10.1016/S0022-2275(20)41220-9
Stimulation of fatty acid biosynthesis by dietary cholesterol and of cholesterol synthesis by dietary fatty acid.
resolves10.1016/S0021-9150(99)00282-8
Governance of the concentration of plasma LDL: a reevaluation of the LDL receptor paradigm
resolves10.1016/0026-0495(95)90104-3
Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects
resolves10.1042/cs0880225
Increased Hepatic Secretion of Very-Low-Density Lipoprotein Apolipoprotein B-100 in Obesity: A Stable Isotope Study
resolves10.1007/BF00400586
Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM
resolves10.2337/diacare.18.10.1362
Effects of Insulin on Cholesterol Synthesis in Type II Diabetes Patients
resolves10.1046/j.1365-2362.1996.138285.x
Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non‐insulin‐dependent diabetes mellitus than in non‐diabetic subjects
resolves10.1007/s001250050700
Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM
resolves10.1161/01.ATV.13.8.1187
Relation of plasma triglyceride and apoB levels to insulin-mediated suppression of nonesterified fatty acids. Possible explanation for sex differences in lipoprotein pattern.
resolves10.1161/01.ATV.17.1.64
Differences in Insulin Suppression of Free Fatty Acid Levels by Gender and Glucose Tolerance Status
resolves10.1016/S0140-6736(63)91500-9
THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUS
resolves10.1172/JCI115534
Fatty acids in the portal vein of the rat regulate hepatic insulin clearance.
resolves10.1210/jcem-58-3-544
The Antilipolytic Action of Insulin in Obese Subjects with Resistance to Its Glucoregulatory Action*
resolves10.1161/01.CIR.68.4.714
Plasma and lipoprotein cholesterol and triglyceride concentrations in the Pima Indians: distributions differing from those of Caucasians.
resolves10.1016/S0022-2275(20)34763-5
Studied of very low density lipoprotein triglyceride metabolism in an obese population with low plasma lipids: lack of influence of body weight or plasma insulin
resolves10.1016/0026-0495(87)90096-5
Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes
resolves10.1161/01.CIR.81.3.987
Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes.
resolves10.1093/oxfordjournals.aje.a117632
Coronary Heart Disease Prevalence and Its Relation to Risk Factors in American Indians
resolves10.1002/j.1550-8528.1999.tb00432.x
Fasting and Postprandial Plasma Concentrations of Acylation‐Stimulation Protein (ASP) in Lean and Obese Pima Indians Compared to Caucasians
resolves10.2337/diab.46.6.983
Skeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action
resolves10.1056/NEJM199908053410604
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
resolves10.1016/0021-9150(94)90062-0
Changes in composition and distribution of LDL subspecies in hypertriglyceridemic and hypercholesterolemic patients during gemfibrozil therapy
resolves10.1161/01.ATV.16.6.763
Fenofibrate Reduces Plasma Cholesteryl Ester Transfer From HDL to VLDL and Normalizes the Atherogenic, Dense LDL Profile in Combined Hyperlipidemia
resolves10.1016/0021-9150(94)05411-B
Effect of gemfibrozil on the concentration and composition of very low density and low density lipoprotein subfractions in hypertriglyceridemic patients
resolves10.1161/01.CIR.101.15.1773
Ciprofibrate Therapy Improves Endothelial Function and Reduces Postprandial Lipemia and Oxidative Stress in Type 2 Diabetes Mellitus
resolves10.1002/(SICI)1520-7560(199911/12)15:6<395::AID-DMRR65>3.0.CO;2-N
Atherogenic lipoprotein phenotype in Type 2 diabetes: reversal with micronised fenofibrate
resolves10.1161/01.CIR.102.1.21
Secondary Prevention by Raising HDL Cholesterol and Reducing Triglycerides in Patients With Coronary Artery Disease
resolves10.1016/S0140-6736(00)04209-4
Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study
resolves10.1016/S0021-9150(98)00198-1
Metabolic modes of action of the statins in the hyperlipoproteinemias
resolves10.1056/NEJM199511163332001
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
resolves10.1001/jama.279.20.1615
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
resolves10.2337/diacare.20.4.614
Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
resolves10.1001/archinte.159.22.2661
Reduced Coronary Events in Simvastatin-Treated Patients With Coronary Heart Disease and Diabetes or Impaired Fasting Glucose Levels
resolves10.1161/01.CIR.98.23.2513
Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels
resolves10.1056/NEJM199811053391902
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
resolves10.1016/0735-1097(94)90635-1
Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol
resolves10.1016/S0021-9150(99)00151-3
The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial
resolves10.1161/01.ATV.20.11.2408
Apolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease Events
resolves10.1161/01.CIR.97.15.1453
Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)
resolves10.1161/01.CIR.101.5.477
Relation Between Baseline and On-Treatment Lipid Parameters and First Acute Major Coronary Events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
The 7 references without a DOI — listed, not checked
no DOI — not checkedr27-14
no DOI — not checkedr39-14
no DOI — not checkedr44-14
no DOI — not checkedr84-14
no DOI — not checkedr100-14
no DOI — not checkedr102-14
no DOI — not checkedr123-14
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.7326/0003-4819-135-6-200109180-00014"><img src="https://citestamp.com/citestamped/10.7326/0003-4819-135-6-200109180-00014/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.7326/0003-4819-135-6-200109180-00014)